Legal & General Group
NERV icon

Legal & General Group’s Minerva Neurosciences NERV Stock Holding History

Legal & General Group’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-509
Closed -$12K – 3596
2021
Q1 		$12K Hold
509
– – ﹤0.01% 3326
2020
Q4 		$10K Hold
509
– – ﹤0.01% 3345
2020
Q3 		$13K Sell
509
-122
-19% -$3.3K ﹤0.01% 3131
2020
Q2 		$18K Buy
631
+29
+5% +$1.7K ﹤0.01% 3106
2020
Q1 		$29K Sell
602
-90
-13% -$5.43K ﹤0.01% 2776
2019
Q4 		$39K Buy
692
+97
+16% +$4.28K ﹤0.01% 2918
2019
Q3 		$37K Hold
595
– – ﹤0.01% 2866
2019
Q2 		$27K Hold
595
– – ﹤0.01% 3079
2019
Q1 		$38K Hold
595
– – ﹤0.01% 2818
2018
Q4 		$32K Hold
595
– – ﹤0.01% 2879
2018
Q3 		$60K Hold
595
– – ﹤0.01% 2688
2018
Q2 		$40K Buy
595
+5
+0.8% +$304 ﹤0.01% 2861
2018
Q1 		$29K Sell
590
-367
-38% -$17.6K ﹤0.01% 2987
2017
Q4 		$47K Sell
957
-197
-17% -$9.77K ﹤0.01% 2888
2017
Q3 		$69K Buy
1,154
+252
+28% +$14.5K ﹤0.01% 2810
2017
Q2 		$63K Buy
902
+171
+23% +$11.1K ﹤0.01% 2834
2017
Q1 		$48K Buy
731
+2
+0.3% +$155 ﹤0.01% 2881
2016
Q4 		$69K Buy
729
+363
+99% +$37.1K ﹤0.01% 2770
2016
Q3 		$40K Hold
366
– – ﹤0.01% 2619
2016
Q2 		$30K Buy
+366
New +$23.3K ﹤0.01% 2737

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legal & General Group's NERV Position: Q2 2021 in Review

Legal & General Group sold out of Minerva Neurosciences (NERV) in Q2 2021, closing a stake of 509 shares — an estimated $12K sold.

Legal & General Group first reported a position in NERV in Q2 2016 and held it in 20 quarters. The position peaked at $69K in Q3 2017. 68 funds tracked by Wall St. Rank hold NERV as of Q2 2021.

  • Legal & General Group reported no remaining Minerva Neurosciences position as of Q2 2021 after selling out during the quarter.
  • Legal & General Group sold 509 Minerva Neurosciences shares in Q2 2021, an estimated $12K.
  • Legal & General Group first reported a position in Minerva Neurosciences in Q2 2016 and held it in 20 quarters.
  • Legal & General Group's Minerva Neurosciences position peaked at $69K in Q3 2017.
  • 68 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q2 2021.

Based on Legal & General Group's 13F filing for Q2 2021, filed 12 Aug 2021.